Disclosure of interest: All authors: nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P718 - ESOC25-1019 TIROFIBAN WITH ENDOVASCULAR TREATMENT FOR ACUTE MILD BASILAR ARTERY OCCLUSION STROKE Yongteng Xu 1 , Yibin Xiao 1 , Dong Pan 1 , Xinguang Yang 1 , Songhua Xiao 1 , Yamei Tang 1 1 Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, Guangzhou, Guangdong Province, China Background and Aims: The effectiveness of tirofiban as an adjunctive treatment for endovascular treatment (EVT) in acute mild basilar artery occlusion (BAO) stroke remains unclear
FAQs The frequency of B12 injections varies: initially, they may be given weekly or biweekly to address severe deficiency, then reduced to monthly or less often for maintenance
Y., Kamenskii, A
The TRIUMPH-4 data confirm that retatrutide achieves greater peak weight loss, but CagriSema's nearer-term availability and established semaglutide safety record may make it the first to reach patients
